AstraZeneca Reps Strike Gold in China’s Provinces

Growing in emerging markets like China is a major goal these days in the drug industry, but the best strategy to reach doctors in the sprawling, heterogeneous Middle Kingdom isn’t clear. AstraZeneca decided six years ago to shun the big cities that most of its competitors focused on, and instead cultivate relationships with local doctors [...]